Whistleblower Case Studies
-
Rapamune In the News
Feb 8
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Tuesday, February 8th, 2011
The Justice Department on Tuesday joined a whistle-blower lawsuit against Pfizer and its subsidiary Wyeth Pharmaceuticals that accuses Wyeth of illegal off-label marketing of Rapamune, a drug used to prevent rejection of kidney transplants.
Reuben A. Guttman, lawyer for two former Wyeth employees, predicted that the government action could result in recovery of hundreds of millions of dollars in inappropriate billings to public health programs. Nineteen states, including New York, and the District of Columbia also joined the filing.
“It…
-
U.S. Lawmakers to Investigate Wyeth Illegal Marketing
Oct 29
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Friday, October 29th, 2010
U.S. Lawmakers to Investigate Wyeth Illegal Marketing…
-
Rapamune
Oct 29
Posted by: Staff | Number of Comments: Comments Off
Category: Whistleblower Case Studies, Whistleblower News | Date Posted: Friday, October 29th, 2010
Grant & Eisenhofer has filed a lawsuit against Wyeth Pharmaceuticals and its parent company, Pfizer, alleging unlawful marketing practices with regard to the immunosuppressant drug, Rapamune. A copy of the lawsuit can be found here….